Back to Journals » Therapeutics and Clinical Risk Management » Volume 14

Increased risk of adverse drug events secondary to bevacizumab treatment in patients with advanced or metastatic breast cancer: a meta-analysis of randomized controlled trials

Total article views   HTML views PDF downloads Totals
8,425 Dovepress* 7,826+ 1,315 9,141
PubMed Central* 599 165 764
Totals 8,425 1,480 9,905
*Since 4 May 2018

View citations on PubMed Central and Google Scholar